news

Mori Hamada & Matsumoto and Davis Polk have advised Japanese beauty company Shiseido on the 160 billion yen ($1.5 billion) sale of its personal care business to private equity firm CVC, which was represented by Nagashima Ohno & Tsunematsu and White & Case.

Baker McKenzie and Morrison Foerster counselling the lead arrangers and mezzanine lenders.

Shiseido is a Japanese multinational cosmetic company founded in Tokyo in 1872, offering premium beauty brands such as NARS Cosmetics, Bare Escentuals and its namesake Shiseido line.

According to CNBC, as part of this strategy, Shiseido is planning to exit its non-core businesses by the end of this year.

The White & Case team was led by partner Clara Shirota, while partners Gavin Raftery and Shinichiro Kitamura led the Baker McKenzie team.

Meanwhile, the Morrison & Foerster team was led by partners Yemi Tépé and Yuhki Asano, while partner Ken Lebrun led the Davis Polk team.

 

Related Articles

Nishimura, MHM advise on Dai-ichi Life’s $2 bln acquisition of Benefit One

by Mari Iwata |

Nishimura & Asahi has advised Japanese life insurance giant Dai-ichi Life Holdings on its 2.9-trillion-yen ($2 billion) acquisition of healthcare platform Benefit One, which was represented by Mori Hamada & Matsumoto.

MHM to expand in Japan with Yokohama office launch

by Mari Iwata |

Leading Japanese law firm Mori Hamada & Matsumoto has announced that it will establish a presence in Yokohama, the nation’s second-largest city. It will be the firm’s seventh domestic office.

Clifford Chance, Nishimura, MHM lead on CVC’s $1.2 bln acquisition of Sogo Medical Group

by Mari Iwata |

Clifford Chance and Nishimura & Asahi have acted for private equity firm CVC Capital Partners on its 17-billion-yen ($1.2 billion) acquisition of Sogo Medical Group, Japan’s fifth-biggest pharmacy by store numbers. Sogo was represented by Mori Hamada & Matsumoto.